Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 51 - 60 of 808 items for :

  • hormone therapy x
Clear All
Panagiotis Anagnostis Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece

Search for other papers by Panagiotis Anagnostis in
Google Scholar
PubMed Close
,
Irene Lambrinoudaki 2nd Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Medical School, Athens, Greece

Search for other papers by Irene Lambrinoudaki in
Google Scholar
PubMed Close
,
John C Stevenson National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield Hospitals, Guy’s and St Thomas’ NHS Foundation Trust, London, UK

Search for other papers by John C Stevenson in
Google Scholar
PubMed Close
, and
Dimitrios G Goulis Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece

Search for other papers by Dimitrios G Goulis in
Google Scholar
PubMed Close

effect of menopausal hormone therapy (MHT) on this risk is also discussed. Does transition to menopause predispose to higher CVD risk? Menopause, defined as the completion of 12 months since the final menstrual period (FMP) or at the time of

Article Type:
Review Article
Collections:
Reproduction
DOI:
https://doi.org/10.1530/EC-21-0537
Volume/Issue:
Volume 11: Issue 4
Open access
Luca Persani Division of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

Search for other papers by Luca Persani in
Google Scholar
PubMed Close
,
Biagio Cangiano Division of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

Search for other papers by Biagio Cangiano in
Google Scholar
PubMed Close
, and
Marco Bonomi Division of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

Search for other papers by Marco Bonomi in
Google Scholar
PubMed Close

follow an adequate treatment with glucocorticoid in order to prevent the induction of an adrenal crisis. On the contrary, thyroid hormones enhance GH sensitivity and rise both IGF1 levels and ALS, thus also increasing GH metabolic effect during therapies

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-18-0515
Volume/Issue:
Volume 8: Issue 2
Open access
Melinda Kertész Department of Medicine and Nephrology-Diabetes Centre, Medical School, University of Pécs, Pécs, Baranya, Hungary

Search for other papers by Melinda Kertész in
Google Scholar
PubMed Close
,
Szilárd Kun Department of Medicine and Nephrology-Diabetes Centre, Medical School, University of Pécs, Pécs, Baranya, Hungary

Search for other papers by Szilárd Kun in
Google Scholar
PubMed Close
,
Eszter Sélley Department of Medicine and Nephrology-Diabetes Centre, Medical School, University of Pécs, Pécs, Baranya, Hungary

Search for other papers by Eszter Sélley in
Google Scholar
PubMed Close
,
Zsuzsanna Nagy Department of Medicine and Nephrology-Diabetes Centre, Medical School, University of Pécs, Pécs, Baranya, Hungary

Search for other papers by Zsuzsanna Nagy in
Google Scholar
PubMed Close
,
Tamás Kőszegi Department of Laboratory Medicine, Medical School, University of Pécs, Pécs, Baranya, Hungary

Search for other papers by Tamás Kőszegi in
Google Scholar
PubMed Close
, and
István Wittmann Department of Medicine and Nephrology-Diabetes Centre, Medical School, University of Pécs, Pécs, Baranya, Hungary

Search for other papers by István Wittmann in
Google Scholar
PubMed Close

, thyroxine; HOMA-IR, homeostasis model assessment-estimated insulin resistance; TSH, thyroid-stimulating hormone. Exclusion criteria were previously initiated metformin therapy or other antidiabetic therapy and known thyroid disease, or treatment

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0218
Volume/Issue:
Volume 10: Issue 7
Open access
Mark R Postma Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by Mark R Postma in
Google Scholar
PubMed Close
,
Pia Burman Department of Endocrinology, Skane University Hospital Malmö, University of Lund, Lund, Sweden

Search for other papers by Pia Burman in
Google Scholar
PubMed Close
, and
André P van Beek Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by André P van Beek in
Google Scholar
PubMed Close

increasingly difficult ( 6 , 7 , 8 ). It is not known whether these changes in SD scores and the likely association of delayed initiation of GHRT result in poorer outcomes. In paediatric growth hormone therapy, it is well known that age of treatment onset

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-20-0098
Volume/Issue:
Volume 9: Issue 7
Open access
Kristin Ottarsdottir Primary Health Care, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Kristin Ottarsdottir in
Google Scholar
PubMed Close
,
Margareta Hellgren Primary Health Care, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Margareta Hellgren in
Google Scholar
PubMed Close
,
David Bock Biostatistics, School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden

Search for other papers by David Bock in
Google Scholar
PubMed Close
,
Anna G Nilsson Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Anna G Nilsson in
Google Scholar
PubMed Close
, and
Bledar Daka Primary Health Care, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Bledar Daka in
Google Scholar
PubMed Close

–2014. Of those, 1327 (participation rate 68%; M = 657) participants completed the study protocol at visit 2 accordingly. Eligible for the present study were those without insulin therapy or hormone replacement therapy. Only subjects that could provide full

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-20-0141
Volume/Issue:
Volume 9: Issue 5
Open access
Dan Liang Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

Search for other papers by Dan Liang in
Google Scholar
PubMed Close
,
Han Chen Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

Search for other papers by Han Chen in
Google Scholar
PubMed Close
, and
Li-Yong Zhong Department of Endocrinology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

Search for other papers by Li-Yong Zhong in
Google Scholar
PubMed Close

-term neuroendocrine outcomes, the multidisciplinary therapy team should consider constant exogenous hormone replacement treatment for sellar-predominant lesions, and reduced hormone replacement dose for non-sellar-predominant patients. To explore therapeutic influence

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-23-0168
Volume/Issue:
Volume 12: Issue 8
Open access
Renata C Scalco Unidade de Endocrinologia Genetica, Laboratorio de Endocrinologia Celular e Molecular LIM/25, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil
Disciplina de Endocrinologia, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, São Paulo, Brazil
Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular LIM/42, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil

Search for other papers by Renata C Scalco in
Google Scholar
PubMed Close
,
Ericka B Trarbach Unidade de Endocrinologia Genetica, Laboratorio de Endocrinologia Celular e Molecular LIM/25, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil

Search for other papers by Ericka B Trarbach in
Google Scholar
PubMed Close
,
Edoarda V A Albuquerque Unidade de Endocrinologia Genetica, Laboratorio de Endocrinologia Celular e Molecular LIM/25, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil

Search for other papers by Edoarda V A Albuquerque in
Google Scholar
PubMed Close
,
Thais K Homma Unidade de Endocrinologia Genetica, Laboratorio de Endocrinologia Celular e Molecular LIM/25, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil

Search for other papers by Thais K Homma in
Google Scholar
PubMed Close
,
Thais H Inoue-Lima Unidade de Endocrinologia Genetica, Laboratorio de Endocrinologia Celular e Molecular LIM/25, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil

Search for other papers by Thais H Inoue-Lima in
Google Scholar
PubMed Close
,
Mirian Y Nishi Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular LIM/42, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil

Search for other papers by Mirian Y Nishi in
Google Scholar
PubMed Close
,
Berenice B Mendonca Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular LIM/42, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil

Search for other papers by Berenice B Mendonca in
Google Scholar
PubMed Close
, and
Alexander A L Jorge Unidade de Endocrinologia Genetica, Laboratorio de Endocrinologia Celular e Molecular LIM/25, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil

Search for other papers by Alexander A L Jorge in
Google Scholar
PubMed Close

, affecting approximately 25–50 per 100,000 females. Hypergonadotropic hypogonadism is a frequent manifestation, present in more than 95% of TS patients. Therefore, most patients will need hormone replacement therapy (HRT) for puberty induction, attaining of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0398
Volume/Issue:
Volume 8: Issue 11
Open access
Anastasia P Athanasoulia-Kaspar Clinical Neuroendocrinology, Max Planck Institute of Psychiatry, Munich, Germany

Search for other papers by Anastasia P Athanasoulia-Kaspar in
Google Scholar
PubMed Close
,
Matthias K Auer Clinical Neuroendocrinology, Max Planck Institute of Psychiatry, Munich, Germany
Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany

Search for other papers by Matthias K Auer in
Google Scholar
PubMed Close
,
Günter K Stalla Clinical Neuroendocrinology, Max Planck Institute of Psychiatry, Munich, Germany

Search for other papers by Günter K Stalla in
Google Scholar
PubMed Close
, and
Mira Jakovcevski Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany

Search for other papers by Mira Jakovcevski in
Google Scholar
PubMed Close

, high doses of glucocorticoid substitution therapy and older age at diagnosis are the most consistently identified risk factors associated with increased morbidity and mortality ( 18 , 19 ). In addition, growth hormone deficiency (GHD) has been linked

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0362
Volume/Issue:
Volume 7: Issue 11
Open access
Ning Yuan Department of Endocrinology, Peking University International Hospital, Beijing, China

Search for other papers by Ning Yuan in
Google Scholar
PubMed Close
,
Jianbin Sun Department of Endocrinology, Peking University International Hospital, Beijing, China

Search for other papers by Jianbin Sun in
Google Scholar
PubMed Close
,
Xin Zhao Department of Endocrinology, Peking University International Hospital, Beijing, China

Search for other papers by Xin Zhao in
Google Scholar
PubMed Close
,
Jing Du Department of Endocrinology, Peking University International Hospital, Beijing, China

Search for other papers by Jing Du in
Google Scholar
PubMed Close
,
Min Nan Department of Endocrinology, Peking University International Hospital, Beijing, China

Search for other papers by Min Nan in
Google Scholar
PubMed Close
,
Qiaoling Zhang Department of Endocrinology, Peking University International Hospital, Beijing, China

Search for other papers by Qiaoling Zhang in
Google Scholar
PubMed Close
, and
Xiaomei Zhang Department of Endocrinology, Peking University International Hospital, Beijing, China

Search for other papers by Xiaomei Zhang in
Google Scholar
PubMed Close

Introduction Maternal subclinical hypothyroidism (SCH), which is defined as an increased thyroid-stimulating hormone (TSH) concentration beyond the upper limit of the pregnancy-specific reference range and a normal free-thyroxine (FT4

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-21-0600
Volume/Issue:
Volume 11: Issue 4
Open access
Guillem Cuatrecasas Endocrinology Department, Hospital Quiron-Teknon, CPEN S.L., Barcelona, Spain
Universitat Oberta Catalunya (UOC), Barcelona, Spain

Search for other papers by Guillem Cuatrecasas in
Google Scholar
PubMed Close
,
Hatice Kumru Institut Guttmann, Institut Universitari de Neurorehabilitació Adscrit a la UAB, Barcelona, Spain
Univ Autònoma de Barcelona, Cerdanyola del Vallès, Spain
Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Barcelona, Spain

Search for other papers by Hatice Kumru in
Google Scholar
PubMed Close
,
M Josep Coves Endocrinology Department, Hospital Quiron-Teknon, CPEN S.L., Barcelona, Spain

Search for other papers by M Josep Coves in
Google Scholar
PubMed Close
, and
Joan Vidal Institut Guttmann, Institut Universitari de Neurorehabilitació Adscrit a la UAB, Barcelona, Spain
Univ Autònoma de Barcelona, Cerdanyola del Vallès, Spain
Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Barcelona, Spain

Search for other papers by Joan Vidal in
Google Scholar
PubMed Close

Introduction Growth hormone deficiency (GHD) has been studied in neurological disorders affecting central nervous systems, such as multiple sclerosis to amyotrophic lateral sclerosis ( 1 , 2 ). Because of the direct impact to the pituitary

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0296
Volume/Issue:
Volume 7: Issue 10
Open access